Annual Cash & Cash Equivalents
$681.10M$305.17M+81.18%
Summary
- Current Value
- As of today, BBIO annual cash & cash equivalents is $681.10M, up +81.18% on
- Historical Performance
- BBIO annual cash & cash equivalents is up +72.97% over the past 3 years, and up +87.23% over the past 5 years
- All-Time High Comparison
- BBIO annual cash & cash equivalents is currently at its all-time high
- 3-Year Low Comparison
- BBIO annual cash & cash equivalents is +81.18% above its 3-year low of $375.94M reached on
- Sector Comparison
- BBIO annual cash & cash equivalents is higher than 91.26% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $681.10M | +81.2% | +73.0% | +87.2% | +640.4% | |
| Quarterly Cash & Cash Equivalents | $646.07M | +59.2% | +9.1% | -9.1% | – | |
| Price | $77.25 | +162.3% | +936.9% | +17.9% | – | |
| Annual Current Assets | $720.69M | +50.9% | -18.9% | +26.7% | +642.0% | |
| Annual Total Liabilities | $2.38B | +25.8% | +26.5% | +1426.6% | +1456.3% | |
| Annual Working Capital | $566.29M | +69.7% | -24.9% | +11.4% | +539.3% | |
| Annual Net Income | -$543.35M | +16.8% | +7.3% | -88.3% | -1139.6% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $681.10M | at high | |
| 5Y | $681.10M | at high | |
| All | $681.10M | at high |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $375.94M | +81.2% | |
| 5Y | $356.08M | N/A | +91.3% |
| All | $92.00M | +640.4% |
Cash and Cash Equivalents History
| Year | Value | Change |
|---|---|---|
| $681.10M | +81.2% | |
| $375.94M | -0.2% | |
| $376.69M | -4.3% | |
| $393.77M | +10.6% |
| Year | Value | Change |
|---|---|---|
| $356.08M | -2.1% | |
| $363.77M | -16.6% | |
| $436.09M | +374.0% | |
| $92.00M | - |
FAQ
What is the current annual cash & cash equivalents of BBIO?
As of today, BBIO annual cash & cash equivalents is $681.10M
What is 1-year change in BBIO annual cash & cash equivalents?
BBIO annual cash & cash equivalents is up +81.18% year-over-year
What is 3-year change in BBIO annual cash & cash equivalents?
BBIO annual cash & cash equivalents is up +72.97% over the past 3 years
How far is BBIO annual cash & cash equivalents from its all-time high?
BBIO annual cash & cash equivalents is currently at its all-time high
How does BBIO annual cash & cash equivalents rank versus sector peers?
BBIO annual cash & cash equivalents is higher than 91.26% of companies in Healthcare sector
When is BBIO next annual earnings release?
The next annual earnings release for BBIO is on
Quarterly Cash & Cash Equivalents
$646.07M$111.27M-14.69%
Summary
- Current Value
- As of today, BBIO quarterly cash & cash equivalents is $646.07M, down -14.69% on
- Historical Performance
- BBIO quarterly cash & cash equivalents is up +59.23% year-over-year, and up +9.11% over the past 3 years
- All-Time High Comparison
- BBIO quarterly cash & cash equivalents is currently -29.72% below its historical high of $919.26M set on
- 3-Year Low Comparison
- BBIO quarterly cash & cash equivalents is +60.03% above its 3-year low of $403.72M reached on
- Sector Comparison
- BBIO quarterly cash & cash equivalents is higher than 88.38% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $646.07M | -14.7% | +59.2% | +9.1% | -9.1% | |
| Annual Cash & Cash Equivalents | $681.10M | – | +81.2% | +73.0% | +87.2% | |
| Price | $77.25 | +41.0% | +162.3% | +936.9% | +17.9% | |
| Quarterly Current Assets | $839.38M | -8.0% | +88.8% | +30.7% | +12.6% | |
| Quarterly Total Liabilities | $2.92B | +2.2% | +55.1% | +57.1% | +413.1% | |
| Quarterly Working Capital | $622.78M | -15.4% | +104.0% | +19.1% | -7.0% | |
| Quarterly Net Income | -$184.94M | -0.6% | -12.6% | -31.9% | -42.1% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $757.34M | -14.7% | |
| 3Y | $757.34M | -14.7% | |
| 5Y | $919.26M | -29.7% | |
| All | $919.26M | -29.7% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $540.73M | +19.5% | |
| 3Y | $403.72M | +60.0% | |
| 5Y | $403.72M | +60.0% | |
| All | $293.80M | +119.9% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of BBIO?
As of today, BBIO quarterly cash & cash equivalents is $646.07M
What is BBIO quarterly cash & cash equivalents most recent change?
BBIO quarterly cash & cash equivalents was down -14.69% on September 30, 2025
What is 1-year change in BBIO quarterly cash & cash equivalents?
BBIO quarterly cash & cash equivalents is up +59.23% year-over-year
How far is BBIO quarterly cash & cash equivalents from its all-time high?
BBIO quarterly cash & cash equivalents is currently -29.72% below its historical high of $919.26M set on March 31, 2021
How does BBIO quarterly cash & cash equivalents rank versus sector peers?
BBIO quarterly cash & cash equivalents is higher than 88.38% of companies in Healthcare sector
When is BBIO next earnings release?
The next earnings release for BBIO is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- BBIO Official Website bridgebio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1743881/000174388125000012/0001743881-25-000012-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1743881/000095017025024119/0000950170-25-024119-index.htm
- BBIO Profile on Yahoo Finance finance.yahoo.com/quote/BBIO
- BBIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bbio